Follow The Filings

LAB position history

The shares of Standard Biotools (LAB) that VIKING GLOBAL INVESTORS LP reported in each quarter’s 13F.

Equity, COM

Shares held by quarter

New Add Reduce Exit

  1. 2024 Q1: 58,651,170 shares, $159M, 0.59% of portfolio, New
  2. 2024 Q2: 58,651,170 shares, $104M, 0.40% of portfolio
  3. 2024 Q3: 58,651,170 shares, $113M, 0.41% of portfolio
  4. 2024 Q4: 58,651,170 shares, $103M, 0.33% of portfolio
  5. 2025 Q1: 58,651,170 shares, $63M, 0.20% of portfolio
  6. 2025 Q2: 58,651,170 shares, $70M, 0.20% of portfolio
  7. 2025 Q3: 58,651,170 shares, $76M, 0.20% of portfolio
  8. 2025 Q4: 58,651,170 shares, $75M, 0.20% of portfolio
  9. 2026 Q1: 58,651,170 shares, $54M, 0.15% of portfolio
  10. 2026 Q2: 58,651,170 shares, $48M, 0.14% of portfolio
Holdings date Value % of holdings Shares Filing date All 13F holders